HPV DNA testing in cervical cancer screening: from evidence to policies (Q46864410)

25 December 2017

title

HPV DNA testing in cervical cancer screening: from evidence to policies (English)

1 reference

25 December 2017

main subject

cervix uterine cancer

1 reference

Tom Cox

1

1 reference

25 December 2017

Jack Cuzick

series ordinal

2

1 reference

25 December 2017

language of work or name

English

0 references

publication date

21 August 2006

1 reference

25 December 2017

published in

Gynecologic Oncology

1 reference

25 December 2017

volume

103

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

8-11

1 reference

25 December 2017

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Management of women who test positive for high-risk types of human papillomavirus: the HART study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Cost-effectiveness of cervical-cancer screening in five developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.030

10.1016/J.YGYNO.2006.07.030

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017